Sign in
Active, not recruitingNo phase

Genetics of Ventriculo-arterial Discordance

Key facts

Who runs it
Nantes University Hospital
Where
France16 sites in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
600 people, planned
Started
7 Sept 2022
Expected to end
24 Jun 2027
Type of study
Interventional
Treatments tested
  • Genetic analyses: whole genome sequencing
Record updated
11 December 2025

Who can take part

Age
1 Minute to 100 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Patients with transposition of the great arteries or transposition congenitally corrected of the great arteries with healthy parents and no family history of congenital heart disease (familial trio)
  • Or patients with transposition of the great arteries or transposition congenitally corrected of the great arteries with or without a history of congenital heart disease (familial form or sporadic case)
  • Affiliated or beneficiaries of a social security scheme or similar
  • After obtaining oral consent from patients and/or parents if applicable; Parents (for family trios) :
  • Biological parents of the child included in the PRECIPED study

Who cannot take part

  • Patient with an identified malformation syndrome
  • Patients with transposition of the great arteries or transposition congenitally corrected of the great arteries with hypoplastic ventricle or atrioventricular and/or ventriculoarterial valve atresia
  • Patients under guardianship/curatorship
  • Patients with State Medical Aid
  • Refusal of consent by the patient and/or one of the two parents

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Number of centres planned : 16 centres in France

Read full original descriptionShow less

Type of study / Study design : Research Involving the Human Person category 2.

Multicentric. Prospective

Planning of the study : Total duration: 57,5 months. Recruitment period: 33.5 months. Follow-up time per patients : 2 years

Expected number of cases : The study will involve a maximum of 900 individuals, from 16 centers in France300 family trios (consisting of 150 index cases and their 2 parents, healthy volunteers, N= 450 individuals)

- In the event of unavailability, refusal, non-compliance with an inclusion or exclusion criterion concerning one of the biological parents, only the index case (patient) will be included in the study without his or her parents.

The 300 index cases with ventriculo-arterial discordance will be divided into two groups: 100 double discordance cases and 200 large-vessel transpositions.

These group inclusion targets are theoretical. If the proportion of patients available for inclusion turns out to be higher than expected for one of the groups, the targets may be adjusted, while maintaining a maximum of 300 cases included (corresponding to 900 subjects if all trios are complete).

Patients and their parents will be informed of the study by their referring cardiologist, and their written consent will be obtained.

Translated with DeepL.com (free version)

Treatment, procedure, combination of procedures under consideration :

* Blood samples for genetic analyses collected at the inclusion visit for patients and parents in case of trio families

Schedule of different visits and examinations :

Inclusion visit:

* Collection of demographic, clinical data from the index case and parents * DNA sampling for genetic research (biocollection) of the index case or family trio * Completion of the quality of life questionnaire

Annual visit with a 2 years follow-up:

* Retrieval of data from the index case * Completion of the quality of life questionnaire

The group in the trial

  • Congenital heart diseaseOther group

    Treatment: Genetic analyses: whole genome sequencing

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Genetics of Ventriculo-arterial Discordance: Towards a PRECIsion Medicine in PEDiatric Cardiology
Record updated
11 December 2025